Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 313 participants.
Also called NCT02104583
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 313 participants
- Sponsor
- Registry
-
NCT02104583 -
2013-004430-15
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada, Czechia, Denmark, Germany, Hungary, Israel, Netherlands, Poland
- Registry status
- Completed
Technical summary
Registry record NCT02104583. Randomized; double masking; primary purpose treatment. Start 2014-09 (actual); primary completion 2016-09 (actual). Results posted on 2019-04-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator
- Acronym
- TEMPO
- Condition
- Ventricular Arrhythmia
- Intervention (Drug)
- Eleclazine
- Intervention (Drug)
- Placebo to match eleclazine
- Lead sponsor
- Gilead Sciences
Record details
- Record id
cardio:ct-nct02104583- Content hash
b0c8665d81d49b006e48963cbae28f7a1cb7dd406396f6b86ca1f13cde27bb17